1. Introduction to Gene Therapy

1.1 History of Gene Therapy

1.2 Vectors of Gene Therapy



2. Global Gene Therapy Market

2.1 Market Overview

2.2 Emerging Trends in Gene Therapy



3. Significance of Cancer Therapeutics in Gene Therapy



4. Current Applications of Gene Therapy to Cancer Treatment

4.1 Cancer Treatments Currently Available

4.2 Approaches to Cancer Gene Therapy

4.3 Gene Therapy Used in Cancer Treatment

4.4 Methods of Inserting Genes into Cancer Patients



5. Cancer Gene Therapy Market Dynamics

5.1 Favorable Parameters for Cancer Gene Therapy

5.2 Issued Involved with Application of Gene Therapy in Cancer Patients

5.3 Cancer Gene Therapy Clinical Insight



6. Regulatory Scenario for Gene Therapy Market

6.1 EU

6.2 US



7. Cancer Gene Therapy Drug Clinical Trial Insight by Phase, Country & Target Indications

7.1 Unknown Phase

7.2 Research

7.3 Preclinical

7.4 Phase I/II

7.5 Phase II

7.6 Phase III



8. Marketed Cancer Gene Therapy Drugs



9. Suspended & Discontinued Cancer Gene Therapy Drug Pipeline

9.1 No Development Reported

9.2 Discontinued

9.3 Suspended



10. Competitive Landscape

10.1 Advantagene

10.2 BioCancell

10.3 Celgene

10.4 Cell Genesys

10.5 Epeius Biotechnologies

10.6 GenVec

10.7 Introgen Therapeutics

10.8 MultiVir

10.9 ZIOPHARM Oncology

10.10 Shenzhen SiBiono GeneTech

List of Figures

Figure 3-1: Gene Therapy by Indication

Figure 5-1: Favorable Parameters for Cancer Gene Therapy

Figure 5-2: Cancer Gene Therapy Drug Clinical Pipeline by Phase (%), 2014

Figure 5-3: Cancer Gene Therapy Drug Clinical Pipeline by Phase (Number of Drugs), 2014

Figure 5-4: Suspended Cancer Gene Therapy Drug by Phase (%), 2014

Figure 5-5: Suspended Cancer Gene Therapy Drug by Phase (Number of Drugs), 2014

Figure 5-6: Discontinued Cancer Gene Therapy Drug by Phase (%), 2014

Figure 5-7: Discontinued Cancer Gene Therapy Drug by Phase (Number of Drugs), 2014

Figure 5-8: No Development Reported Cancer Gene Therapy Drug by Phase (%), 2014

Figure 5-9: No Development Reported Cancer Gene Therapy Drug by Phase (Number of

Drugs), 2014

Companies Mentioned

Advantagene,
BioCancell,
Celgene,
Cell Genesys,
Epeius Biotechnologies,
GenVec,
Introgen Therapeutics,
MultiVir,
ZIOPHARM Oncology,
Shenzhen SiBiono GeneTech